Evolus Inc
F:EVL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Evolus Inc
F:EVL
|
US |
|
A
|
Adler Group SA
DUS:ADJ
|
LU |
|
E
|
Eli Lilly and Co
DUS:LLY
|
US |
|
T
|
Thaire Life Assurance PCL
SET:THREL
|
TH |
|
S
|
Schindler Holding AG
SWB:SHRQ
|
CH |
|
Q
|
Quanta Services Inc
F:QAA
|
US |
|
Juventus FC SpA
F:JUV
|
IT |
|
Gecina SA
PAR:GFC
|
FR |
|
Ke Holdings Inc
F:KE8
|
CN |
|
N
|
Nextera Energy Inc
XMUN:FP3
|
US |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
XMUN:LSPP
|
CH |
|
G
|
Getlink SE
XMUN:TNU3
|
FR |
|
P
|
PNC Financial Services Group Inc
F:PNP
|
US |
|
Recruit Holdings Co Ltd
TSE:6098
|
JP |
|
I
|
ImmunoGen Inc
XMUN:IMU
|
US |
|
Phenom Resources Corp
F:1PY0
|
CA |
Bankruptcy Probability
Evolus Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Evolus Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Evolus Inc
NASDAQ:EOLS
|
410.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
931.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
540.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
281B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Evolus Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Evolus Inc has total debt of 146.1m USD. This includes both short-term (0 USD) and long-term (146.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
